Sarepta Therapeutics | Passivo Circulante





Passivo Circulante Alterar Data
Acadia Pharmaceuticals USD 356.58M 26.56M 2025-09
Agios Pharmaceuticals USD 74.76M 4.35M 2025-09
Alnylam Pharmaceuticals USD 1.56B 254.63M 2025-09
Amgen USD 21.79B 1.32B 2025-09
Biogen USD 3.29B 106.3M 2025-09
BioMarin Pharmaceutical USD 798.44M 114.19M 2025-09
Daiichi Sankyo JPY 778.55B 77.51B 2025-12
Eli Lilly USD 40.14B 1.12B 2025-09
Gilead Sciences USD 12.3B 1.11B 2025-09
Incyte USD 1.34B 60.11M 2025-09
Insmed USD 417.21M 105.53M 2025-09
Ionis Pharmaceuticals USD 903.46M 6.22M 2025-09
Moderna USD 1.68B 109M 2025-09
Neurocrine Biosciences USD 638M 91.7M 2025-09
Pfizer USD 36.6B 1.13B 2025-09
PTC Therapeutics USD 866.24M 238.44M 2025-09
Regeneron Pharmaceuticals USD 4.43B 758.1M 2025-09
Roche Holding CHF 28B 421M 2025-12
Sanofi EUR 28.35B 3.76B 2025-12
Sarepta Therapeutics USD 921.42M 1.48M 2025-09
Tectonic Therapeutic USD 9.37M 1.99M 2025-09
Ultragenyx Pharmaceutical USD 340.02M 46.78M 2025-09
Vertex Pharmaceuticals USD 4.48B 336.9M 2025-09


Sarepta Therapeutics Passivo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Feb 2026.